Creathor Ventures

Creathor Venture Management GmbH is a venture capital firm established in 2003, headquartered in Bad Homburg, Germany, with an additional office in Zurich, Switzerland. The firm specializes in seed to early-stage investments in technology-oriented and life science companies, particularly those involved in automation, digital health, and personalized healthcare. Creathor Venture targets investments in sectors such as machine intelligence, Industry 4.0, digital health, diagnostics, and drug development. The firm focuses on companies based in Germany, Austria, France, Switzerland, and other parts of Europe, with initial investment sizes ranging from €0.5 million to €2.5 million. Creathor Venture typically seeks to take on a lead investor role and aims to exit investments through IPOs or trade sales. With a management team that has financed over 200 companies and currently supports over 30 portfolio companies, Creathor Venture manages a fund volume exceeding 230 million euros.

Cedric Kohler

Managing Partner

DR.GERT KÖHLER

Founder and Chairman

Karlheinz Schmelig

Managing Partner

Gert Köhler Ph.D

Founder and Chairman

92 past transactions

HeyJobs

Series B in 2022
HeyJobs operates a talent acquisition platform designed to streamline the employee recruitment process by leveraging artificial intelligence and machine learning technologies. The platform identifies candidates that closely match job profiles and engages them through a personalized application and assessment process. This innovative approach allows employers to recruit skilled workers efficiently and at a lower cost compared to traditional hiring methods. With a track record of over 50,000 successful hires, HeyJobs aims to connect individuals with fulfilling job opportunities while providing quality candidates to its clients.

Ledgy

Series A in 2021
Ledgy AG, a technology company, operates Software-as-a-Service platform to manage and exchange securities in private companies. Its platform is used for shares management for companies and shareholders. The company was founded in 2017 and is based in Zurich, Switzerland.

Humanoo

Series B in 2021
HUMANOO is a digital health platform. HUMANOO boosts the company’s performance, balancing the body and mind of employees and providing tailored and customized daily exercises. HUMANOO aims to promote health and increase overall wellbeing, reducing the number of annual doctor’s visits and increasing happiness both in the workplace and in private life.

Wunderflats

Series C in 2021
Wunderflats GmbH operates an online platform that facilitates the search and rental of furnished apartments in major German cities, including Berlin, Munich, Hamburg, Frankfurt, Düsseldorf, and Cologne. Founded in 2014 and headquartered in Berlin, the company connects tenants, landlords, and businesses, simplifying the process of finding suitable accommodation. Its platform caters to various needs, offering options for family homes, business apartments, student housing, and more, thereby creating a comprehensive housing ecosystem that enhances the rental experience for all users.

Lengoo

Series B in 2021
lengoo powers the future of translation. The AI-first translation tech company has automated the custom-training of neural machine translation systems for enterprise customers, who use the service to have professional translations made in more than 400 language combinations. Over 3,000 business clients, including some of Europe’s biggest enterprises and unicorns, already trust in lengoo’s technology. Headquartered in Berlin, the company was founded in 2014 in Karlsruhe by Philipp Koch-Büttner, Christopher Kränzler, and Alexander Gigga. In 2016, lengoo participated in the Techstars accelerator program in Berlin and in 2018 was awarded with the Deloitte Fast 50 Award as one of the fastest-growing tech companies in Germany with over 600% growth. Christopher Kränzler also holds a seat on the Board of Directors at bitkom, Germany's digital association. Find more info on https://www.lengoo.com lengoo is a certified Language Service Provider according to ISO 17100 and ISO 18587. Find out more! Success stories: https://www.lengoo.com/references Join the team: https://www.lengoo.com/careers

Tacalyx

Seed Round in 2019
Tacalyx GmbH operates as an oncology company, which focuses on the discovery and development of Tumor Associated Carbohydrate Antigen (TACA) antibodies to treat cancer. It provides technology platform for TACAs as novel targets for cancer therapy. The company is based in Berlin, Germany.

Lengoo

Series A in 2019
lengoo powers the future of translation. The AI-first translation tech company has automated the custom-training of neural machine translation systems for enterprise customers, who use the service to have professional translations made in more than 400 language combinations. Over 3,000 business clients, including some of Europe’s biggest enterprises and unicorns, already trust in lengoo’s technology. Headquartered in Berlin, the company was founded in 2014 in Karlsruhe by Philipp Koch-Büttner, Christopher Kränzler, and Alexander Gigga. In 2016, lengoo participated in the Techstars accelerator program in Berlin and in 2018 was awarded with the Deloitte Fast 50 Award as one of the fastest-growing tech companies in Germany with over 600% growth. Christopher Kränzler also holds a seat on the Board of Directors at bitkom, Germany's digital association. Find more info on https://www.lengoo.com lengoo is a certified Language Service Provider according to ISO 17100 and ISO 18587. Find out more! Success stories: https://www.lengoo.com/references Join the team: https://www.lengoo.com/careers

Wunderflats

Series B in 2019
Wunderflats GmbH operates an online platform that facilitates the search and rental of furnished apartments in major German cities, including Berlin, Munich, Hamburg, Frankfurt, Düsseldorf, and Cologne. Founded in 2014 and headquartered in Berlin, the company connects tenants, landlords, and businesses, simplifying the process of finding suitable accommodation. Its platform caters to various needs, offering options for family homes, business apartments, student housing, and more, thereby creating a comprehensive housing ecosystem that enhances the rental experience for all users.

CryoTherapeutics

Series B in 2019
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.

HeyJobs

Series A in 2019
HeyJobs operates a talent acquisition platform designed to streamline the employee recruitment process by leveraging artificial intelligence and machine learning technologies. The platform identifies candidates that closely match job profiles and engages them through a personalized application and assessment process. This innovative approach allows employers to recruit skilled workers efficiently and at a lower cost compared to traditional hiring methods. With a track record of over 50,000 successful hires, HeyJobs aims to connect individuals with fulfilling job opportunities while providing quality candidates to its clients.

Serinus

Seed Round in 2019
Serinus was named after one of the first alarm systems in history: canaries. Latin "Serinus canaria forma domestica" called. In mining, they should warn of escaping carbon monoxide underground. When the birds stopped singing, the mates immediately left the tunnel. The canary is more than just a logo and namesake.

Ledgy

Seed Round in 2018
Ledgy AG, a technology company, operates Software-as-a-Service platform to manage and exchange securities in private companies. Its platform is used for shares management for companies and shareholders. The company was founded in 2017 and is based in Zurich, Switzerland.

iFunded

Series A in 2018
iFunded is the new online market place for global online real estate investments using the state of the art technology. iFunded makes real estate investing highly accessible, simple, transparent and affordable. Private & institutional Investors can invest alongside experts from the real estate industry and participate in the development of selected real estate projects and generate high returns. Real Estate Developers get access to an alternative financing opportunity. In addition they can increase public awareness in the early phase of their project and profit from the marketing effect on the platform of iFunded. iFunded accompanies as an investor throughout the entire investing process: from selecting the right real estate project for from their platform, to the right investment strategy for , to continuous information on current investments. In order to provide with a variety of real estate projects, we cooperate with national and international building contractors and project developers. Their investments are transparent - can inform on the progress of the project invested in at any time online. private / institutional investor dashboard will supply with current market data and reports.

Imverse

Seed Round in 2018
Imverse SA is a Swiss company specializing in the development of software for Mixed Reality content creation. Founded in 2017 and based in Plan-les-Ouates, the company has created a platform that allows users to transform 360-degree images from 2D to 3D, enabling real-time virtual and augmented reality experiences with the aid of virtual reality glasses. Imverse offers B2B services that simplify the creation of immersive VR/MR experiences, including live hologram actors and real-time visual effects derived from single 360° photos. The company's proprietary voxel engine underpins its volumetric technology, which is designed for various applications, including live broadcasting, telepresence, and location-based entertainment. Imverse aims to enhance communication and content creation through innovative graphics technology, fostering deeper connections and engagement for enterprise users.

Klara

Series A in 2018
Klara’s end-to-end patient engagement platform enables healthcare organizations to easily communicate with patients, provide virtual care, collaborate as a team, and automate many front-desk tasks. Thousands of healthcare teams across more than 40 specialties use Klara to make their workflows more efficient, deliver an exceptional patient experience across the entire care journey, and grow their patient volume.

Allthings

Series A in 2018
Allthings Technologies AG, founded in 2013 and headquartered in Basel, Switzerland, specializes in digital communication and interaction within the real estate sector. The company has developed a mobile application that connects property owners, service providers, and tenants, facilitating seamless communication. Allthings offers modular micro-apps that integrate with its platform through APIs, enabling users to access information about their apartments and related services. The company's solutions cater to real estate asset managers, developers, and property managers, aiming to optimize operational efficiency while enhancing property value. With additional offices in Berlin and Freiburg im Breisgau, Germany, Allthings continues to innovate in the digital property management landscape.

Haja Networks

Venture Round in 2018
Haja Networks Oy, founded in 2018 and based in Kempele, Finland, focuses on developing foundational technologies for a decentralized Internet. The company is known for its work on OrbitDB, a scalable and trustless peer-to-peer database, along with database protocols aimed at creating a global data layer that promotes the re-decentralization of the web. Haja Networks prioritizes open-source development, transparency, and diversity, allowing for interoperability among various structured data sources. Their technologies enable a marketplace for decentralized database services, helping providers monetize their software while offering businesses and users straightforward access to essential services and control over their data.

Acousia Therapeutics

Series B in 2018
Acousia Therapeutics GmbH is a biotech company that specializes in identifying small molecules for the treatment of hearing loss. It develops drugs for local application, which protect hearing function or restore hearing in patients who have lost their hearing ability due to various reasons, such as noise trauma, treatment with ototoxic drugs, or sudden deafness. The company was founded in 2012 and is based in Tubingen, Germany.

Humanoo

Series A in 2018
HUMANOO is a digital health platform. HUMANOO boosts the company’s performance, balancing the body and mind of employees and providing tailored and customized daily exercises. HUMANOO aims to promote health and increase overall wellbeing, reducing the number of annual doctor’s visits and increasing happiness both in the workplace and in private life.

Wunderflats

Series A in 2017
Wunderflats GmbH operates an online platform that facilitates the search and rental of furnished apartments in major German cities, including Berlin, Munich, Hamburg, Frankfurt, Düsseldorf, and Cologne. Founded in 2014 and headquartered in Berlin, the company connects tenants, landlords, and businesses, simplifying the process of finding suitable accommodation. Its platform caters to various needs, offering options for family homes, business apartments, student housing, and more, thereby creating a comprehensive housing ecosystem that enhances the rental experience for all users.

Blueprint Genetics

Series A in 2017
Blueprint Genetics Oy, founded in 2012 and based in Helsinki, Finland, specializes in clinical genetics testing with a focus on rare diseases. The company utilizes advanced Next-Generation Sequencing (NGS) technologies, including its proprietary OS-Seq™ method developed at Stanford University, to deliver high-quality genetic diagnostics. Targeting hospitals and research groups, Blueprint Genetics offers a range of services, including tailored sequencing projects and bioinformatics platforms designed to meet specific needs. The company aims to disrupt the genetic diagnostics market by reducing costs while enhancing quality and providing clinical insights in its results. Its product offerings currently include diagnostics for various hereditary conditions, particularly those affecting the cardiovascular system, such as cardiomyopathies, arrhythmias, and aortic diseases. Blueprint Genetics also operates an office in Los Angeles, California, and functions as a subsidiary of Quest Diagnostics Incorporated.

Allthings

Seed Round in 2017
Allthings Technologies AG, founded in 2013 and headquartered in Basel, Switzerland, specializes in digital communication and interaction within the real estate sector. The company has developed a mobile application that connects property owners, service providers, and tenants, facilitating seamless communication. Allthings offers modular micro-apps that integrate with its platform through APIs, enabling users to access information about their apartments and related services. The company's solutions cater to real estate asset managers, developers, and property managers, aiming to optimize operational efficiency while enhancing property value. With additional offices in Berlin and Freiburg im Breisgau, Germany, Allthings continues to innovate in the digital property management landscape.

Ingrid Cloud

Venture Round in 2017
Adaptive Simulations offers a cloud-based service (SaaS), providing customers with fully automated flow simulations. It's automated cloud-solution increases accuracy, flexibility and cost efficiency when simulating flow. The accessibility and ease of use of the solution enables designers and architects without any prior knowledge of Computational Fluid Dynamics (CFD) or simulations to accelerate and improve their design.

R3 Solutions

Seed Round in 2017
R3 Solutions, also known as Reliable Realtime Radio Communications GmbH, was established in July 2015 as a spin-off from two prominent engineering universities. The company specializes in the research, development, production, and distribution of ultra-reliable low-latency wireless communication systems tailored for industrial applications. By enhancing commercial off-the-shelf wireless modules, R3 Solutions significantly reduces setup costs and time, allowing clients to optimize their production layouts. The company's innovative technologies also minimize the reliance on costly sensors, thereby streamlining operational efficiencies for its customers.

iFunded

Seed Round in 2016
iFunded is the new online market place for global online real estate investments using the state of the art technology. iFunded makes real estate investing highly accessible, simple, transparent and affordable. Private & institutional Investors can invest alongside experts from the real estate industry and participate in the development of selected real estate projects and generate high returns. Real Estate Developers get access to an alternative financing opportunity. In addition they can increase public awareness in the early phase of their project and profit from the marketing effect on the platform of iFunded. iFunded accompanies as an investor throughout the entire investing process: from selecting the right real estate project for from their platform, to the right investment strategy for , to continuous information on current investments. In order to provide with a variety of real estate projects, we cooperate with national and international building contractors and project developers. Their investments are transparent - can inform on the progress of the project invested in at any time online. private / institutional investor dashboard will supply with current market data and reports.

HAPPYCAR

Series A in 2016
HAPPYCAR GmbH, founded in 2013 and based in Hamburg, Germany, operates as a meta-search engine for rental cars, allowing users to compare offers from over 250 car rental companies across Germany, France, Portugal, Spain, and the United States. The platform provides extensive transparency by showcasing details such as insurance packages, kilometer fees, and one-way fees, ensuring customers have a clear understanding of their rental options. HAPPYCAR aims to facilitate a user-friendly booking process with a free customer service hotline to address inquiries, thereby enhancing the rental experience. By offering a comprehensive overview of rental deals, HAPPYCAR helps customers save both time and money, positioning itself as one of the fastest-growing online car rental services in Europe.

CryoTherapeutics

Series B in 2016
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.

fromAtoB

Series A in 2016
fromAtoB GmbH operates a travel search engine that compares and combines various means of transportation in Europe, North America, and internationally. It offers deals and information about trains, flights, ride share, long distance buses, taxis, rental cars, public transportation, and route planner, as well as helping users to book transport with providers for their next trip. The company was founded in 2008 and is based in Munich, Germany.

Humanoo

Seed Round in 2016
HUMANOO is a digital health platform. HUMANOO boosts the company’s performance, balancing the body and mind of employees and providing tailored and customized daily exercises. HUMANOO aims to promote health and increase overall wellbeing, reducing the number of annual doctor’s visits and increasing happiness both in the workplace and in private life.

HeyJobs

Seed Round in 2016
HeyJobs operates a talent acquisition platform designed to streamline the employee recruitment process by leveraging artificial intelligence and machine learning technologies. The platform identifies candidates that closely match job profiles and engages them through a personalized application and assessment process. This innovative approach allows employers to recruit skilled workers efficiently and at a lower cost compared to traditional hiring methods. With a track record of over 50,000 successful hires, HeyJobs aims to connect individuals with fulfilling job opportunities while providing quality candidates to its clients.

COBI

Series A in 2016
COBI GmbH, founded in 2014 and based in Frankfurt, Germany, specializes in developing smart connected biking systems aimed at enhancing the cycling experience. The company's flagship product, COBI, is a modular system that integrates a bicycle with a smartphone, transforming traditional bikes into smart bikes. This innovative system incorporates multiple features, including navigation, a smartphone holder with charging capability, an alarm system, a bell, and bike computer functionalities, all designed to improve safety, convenience, and enjoyment while cycling. COBI also offers the potential for hardware and software upgrades and provides a developer SDK for third-party applications and devices. As of September 2017, COBI GmbH operates as a subsidiary of Bosch eBike Systems.

Knip

Series B in 2015
Knip AG, founded in September 2013 by Dennis Just and Christina Kehl, is a Zurich-based company specializing in mobile insurance management. The Knip app allows users to efficiently track their insurance policies, premiums, and benefits. Users receive biannual financial reviews to help them compare tariffs and products. The company employs over 100 staff members across Zurich, Berlin, and Belgrade, and provides personalized advice on various insurance matters. Users can electronically adjust their premiums, initiate new policies, or cancel existing ones, all while benefiting from the company's commitment to transparency and unbiased guidance. Knip AG was acquired by Komparu B.V. in June 2017 and is backed by venture capital from the U.S., Switzerland, Germany, and the Netherlands. The company is also registered with the German Chamber of Industry & Commerce and certified by the German Technical Inspection Agency.

HAPPYCAR

Seed Round in 2015
HAPPYCAR GmbH, founded in 2013 and based in Hamburg, Germany, operates as a meta-search engine for rental cars, allowing users to compare offers from over 250 car rental companies across Germany, France, Portugal, Spain, and the United States. The platform provides extensive transparency by showcasing details such as insurance packages, kilometer fees, and one-way fees, ensuring customers have a clear understanding of their rental options. HAPPYCAR aims to facilitate a user-friendly booking process with a free customer service hotline to address inquiries, thereby enhancing the rental experience. By offering a comprehensive overview of rental deals, HAPPYCAR helps customers save both time and money, positioning itself as one of the fastest-growing online car rental services in Europe.

Kyto

Seed Round in 2015
Kyto is a Software-as-a-service company, which supports small and medium enterprises in optimizing and increasing their international online B2B presence. The proprietary platform synchronizes entered company and product data with a global network of business directories, market places, and search engines. In this way Kyto allows its customers to generate more leads and sales online in a cost and time efficient way. Kyto is supported by recognized investors and experts, and has established a strong network of international publishing partners, such as Europages, IndustryStock, EC21 and more. Kyto is headquartered in Berlin and was founded in May 2013 by Dr. Martin Mittermeier and Paul Wulff.

Cevec

Venture Round in 2015
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.

Bitbar

Series A in 2015
Bitbar Technologies Ltd. is a technology company based in Helsinki, Finland, specializing in cloud-based mobile application testing solutions. Established in 2009, Bitbar offers a range of services designed for mobile app and game developers, including automated software build and testing environments. Its product offerings include Testdroid Cloud, which allows for testing applications on real Android and iOS devices, and Testdroid Enterprise, an in-house solution for managing automated testing across multiple devices. Additionally, Bitbar provides Testdroid PrivateCloud, enabling access to a selection of real devices for development and testing purposes, along with Testdroid Recorder for capturing user actions and generating reusable test cases. The company serves diverse industries such as gaming, technology, e-commerce, and financial services, with notable clients including Facebook, Google, and eBay. In 2019, Bitbar became a subsidiary of SmartBear Software Inc.

COBI

Seed Round in 2015
COBI GmbH, founded in 2014 and based in Frankfurt, Germany, specializes in developing smart connected biking systems aimed at enhancing the cycling experience. The company's flagship product, COBI, is a modular system that integrates a bicycle with a smartphone, transforming traditional bikes into smart bikes. This innovative system incorporates multiple features, including navigation, a smartphone holder with charging capability, an alarm system, a bell, and bike computer functionalities, all designed to improve safety, convenience, and enjoyment while cycling. COBI also offers the potential for hardware and software upgrades and provides a developer SDK for third-party applications and devices. As of September 2017, COBI GmbH operates as a subsidiary of Bosch eBike Systems.

Memorado

Series A in 2015
Memorado is the leading mobile gym for the brain. They strive to significantly improve people’s quality of life around the world through brain training based on neuroscience. Their goal is to redefine how people think about mental performance and help them unlock their true potential. Based in Berlin, they have attracted $5M in funding from some of the best investors across Europe. In just 12 months they are already serving over 4 million members in 25 languages across 229 countries. Memorado has also launched the “Global Cognition Initiative (GCI)”, an open-source research collaboration connecting Memorado's in-house scientists with scientists, researchers, practitioners and teachers around the world who are interested in the research on cognition.

Sinopsys Surgical

Series C in 2015
Sinopsys Surgical, Inc. develops therapies for the treatment of chronic sinus disease (CRS). It manufactures devices including Sinopsys Lacrimal Stent (SLS) and Lacrimal Ethmoid Access Procedure (LEAP). Sinopsys Surgical, Inc. was formerly known as DCS Surgical, Inc. The company was founded in 2011 and is based in Boulder, Colorado.

Klara

Seed Round in 2015
Klara’s end-to-end patient engagement platform enables healthcare organizations to easily communicate with patients, provide virtual care, collaborate as a team, and automate many front-desk tasks. Thousands of healthcare teams across more than 40 specialties use Klara to make their workflows more efficient, deliver an exceptional patient experience across the entire care journey, and grow their patient volume.

Mila

Venture Round in 2015
Mila AG is a mobile community marketplace that connects users with local service providers for various tasks and products. Founded in 2013 and headquartered in Zürich, Switzerland, the company has expanded its presence with offices in Shanghai, New York, London, and Cluj-Napoca. Mila aims to facilitate access to technological advancements by allowing users to find expert assistance in their neighborhoods on demand. The platform is designed to be user-friendly and affordable, ensuring that individuals who may not have the time or technical expertise can still benefit from modern innovations. As of October 2015, Mila operates as a subsidiary of Swisscom AG.

Chundsell Medicals

Venture Round in 2015
Chundsell Medicals AB, established in 2007 as a spin-off from Karolinska Institutet in Solna, Sweden, specializes in the development of diagnostic tests for prostate cancer. The company's primary product, the Prostatype® Test System, evaluates the aggressiveness of prostate cancer by analyzing the expression patterns of three specific embryonic stem cell genes in tumor tissue samples. This assessment is used alongside established clinical parameters to aid healthcare professionals in predicting disease outcomes, overall survival, and cancer-specific survival for patients. Additionally, Chundsell Medicals has developed the Prostate Cancer Prediction Test (PCPT), designed to assist in the early detection and treatment planning for prostate cancer. Through its innovations, Chundsell Medicals aims to enhance the accuracy of prostate cancer diagnosis and improve patient management strategies.

AYOXXA

Series B in 2014
AYOXXA Biosystems GmbH is a biotechnology company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in life science tools, particularly through its proprietary technology platform for multiplexed protein analysis. The company has developed an innovative biochip technology that enables the simultaneous measurement of multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's platform utilizes an in-situ encoded bead array, facilitating the identification and quantification of proteins and biomolecular analytes. This advanced approach to biomarker analysis positions AYOXXA at the forefront of diagnostic technology, allowing for comprehensive testing in a single assay.

Kyto

Venture Round in 2013
Kyto is a Software-as-a-service company, which supports small and medium enterprises in optimizing and increasing their international online B2B presence. The proprietary platform synchronizes entered company and product data with a global network of business directories, market places, and search engines. In this way Kyto allows its customers to generate more leads and sales online in a cost and time efficient way. Kyto is supported by recognized investors and experts, and has established a strong network of international publishing partners, such as Europages, IndustryStock, EC21 and more. Kyto is headquartered in Berlin and was founded in May 2013 by Dr. Martin Mittermeier and Paul Wulff.

Mobiles Republic

Series B in 2013
Mobiles Republic is a digital platform specializing in news applications for smartphones and tablets, based in Bordeaux Cedex, France. The company collaborates with over 800 prominent global and regional news sources, including Associated Press, The Huffington Post, and The Guardian. Its suite of mobile applications includes News Republic®, Appy Geek™, Appy Gamer™, Sports Republic™, and GlamLife™, catering to diverse interests. Mobiles Republic's innovative technology, particularly its proprietary TagNav® system, allows for personalized news delivery based on user preferences across more than one million topics. The platform generates over 10 million page views daily by providing licensed and trusted content, and it also serves as a technology partner for mobile innovations like BlinkFeed™, enhancing user experience on devices such as the HTC One smartphones.

News Republic

Series B in 2013
News Republic, Inc. is a mobile media company headquartered in Bordeaux, France, with an additional presence in San Francisco. Founded in 2008, the company specializes in developing news applications that deliver a wide range of content, including articles, videos, and photos, sourced from numerous media partners worldwide. Its flagship apps, News Republic, AppyGeek, and AppyGamer, are available in six languages and cater to millions of users across various platforms, including iOS, Android, Windows 8, and Tizen. News Republic aims to enhance the news consumption experience through its proprietary semantic engine, which provides real-time contextual news tailored to individual preferences. The company has established strong partnerships with over 1,000 leading publishers and global media brands, as well as collaborations with hardware manufacturers and mobile network operators, further expanding its reach in the mobile news landscape.

Toroleo

Venture Round in 2013
As a product- and price-comparison website focussed on the automotive space, Toroleo helps those who search online for products and services related to motor vehicles to find the best offers and retailers. Toroleo was founded in Berlin in May 2012 by Manuel Hinz with a seed investment from Project A Ventures.

Roombeats

Seed Round in 2013
Roombeats turns every image into an interactive display window. For publishers and bloggers, it offers Affiliate Marketing with Pictures; readers who discover a product image are now able to learn more about this item and are given a link so that they can buy it. Roombeats provides manufacturers with a complete solution to Image Content Marketing by linking images to relevant product and brand information and then distributing this throughout the Web. This increases brand presence online and directs interested customers straight to an online shop. Manufacturers receive real time reporting on the performance of their product images online. This Berlin startup was founded in 2012 by Markus Berger-de Léon, formerly CEO of Jamba, MyHammer and StudiVZ, and Florian Beba, the onetime Head of User Experience with Zalando.

Zimory

Venture Round in 2013
Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloud environments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.

Shopgate

Series B in 2013
Shopgate GmbH specializes in mobile shopping solutions, providing a mobile-commerce-as-a-service platform that enhances mobile sales for online retailers. Founded in 2009 and headquartered in Butzbach, Germany, with additional offices in Frankfurt, Magdeburg, and Austin, Texas, Shopgate enables over 12,000 merchants to create, maintain, and optimize native apps and mobile websites for various devices, including iPhone, iPad, and Android smartphones and tablets. The company offers a user-friendly software-as-a-service (SaaS) that integrates with more than 60 popular shopping carts and collaborates with leading mobile payment providers, ensuring a seamless shopping experience for millions of customers daily. With a dedicated team of 141 individuals, Shopgate emphasizes innovation and customer satisfaction in the rapidly evolving mobile commerce market.

Chundsell Medicals

Venture Round in 2013
Chundsell Medicals AB, established in 2007 as a spin-off from Karolinska Institutet in Solna, Sweden, specializes in the development of diagnostic tests for prostate cancer. The company's primary product, the Prostatype® Test System, evaluates the aggressiveness of prostate cancer by analyzing the expression patterns of three specific embryonic stem cell genes in tumor tissue samples. This assessment is used alongside established clinical parameters to aid healthcare professionals in predicting disease outcomes, overall survival, and cancer-specific survival for patients. Additionally, Chundsell Medicals has developed the Prostate Cancer Prediction Test (PCPT), designed to assist in the early detection and treatment planning for prostate cancer. Through its innovations, Chundsell Medicals aims to enhance the accuracy of prostate cancer diagnosis and improve patient management strategies.

Bitbar

Venture Round in 2013
Bitbar Technologies Ltd. is a technology company based in Helsinki, Finland, specializing in cloud-based mobile application testing solutions. Established in 2009, Bitbar offers a range of services designed for mobile app and game developers, including automated software build and testing environments. Its product offerings include Testdroid Cloud, which allows for testing applications on real Android and iOS devices, and Testdroid Enterprise, an in-house solution for managing automated testing across multiple devices. Additionally, Bitbar provides Testdroid PrivateCloud, enabling access to a selection of real devices for development and testing purposes, along with Testdroid Recorder for capturing user actions and generating reusable test cases. The company serves diverse industries such as gaming, technology, e-commerce, and financial services, with notable clients including Facebook, Google, and eBay. In 2019, Bitbar became a subsidiary of SmartBear Software Inc.

Kigo

Series A in 2013
An innovative and dynamic startup, Kigo offers vacation rental software and channel manager solutions designed for the unique needs of vacation rental managers. Kigo provides reservation systems, SEO friendly websites, with templates or a custom design, completely integrated with the calendar & booking systems, and channel manager solutions to help vacation rental professionals increase bookings. Located in the US, Spain and Thailand, Kigo has an international team with backgrounds as diverse as software business, programming, political science and sales.

SIRION BIOTECH

Venture Round in 2013
Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery of new drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing. The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector. The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.

Iconicfuture

Series B in 2013
Iconicfuture GmbH offers brand licensing solutions for games and digital application developers. The company provides Launchpad, a digital brand licensing platform. Additionally, it offers intellectual property (IP) integration strategy, brand engagement campaigns, reporting, and pricing and business model consulting services. Iconicfuture GmbH was founded in 2011 and is headquartered in Hamburg, Germany.

Cube Biotech

Series A in 2012
Cube Biotech offers innovative products and solutions for membrane protein research – a hotspot for pharmaceutical research. The business model is a two pillared model based on a service business unit that has the potential to generate significant milestone payments and a product business that is securing a constant revenue stream. The major focus of Cube’s service business unit is the structural analysis of membrane proteins – a highly sought after discipline. Those play a crucial role in the aetiology of various diseases and are one of the most sought after targets in drug discovery. Structural analysis of membrane proteins is still a huge challenge. This is particularly true for pharmaceutically relevant human membrane proteins, e.g. transporters or G-protein coupled receptors (GPCRs). The design of efficient drugs depends on the availability of membrane protein structure information. The competitive advantage of Cube is the coverage of the full value chain in membrane protein research through both value adding products and services based on an unique technology. With this portfolio Cube offers unseen opportunities in membrane protein research for customers in the pharmaceutical and biotechnological industry and aca-demia. The relevance of the scientific arena Cube is operating in was recently confirmed with the award of the 2012’s Nobel Prize in chemistry for two US-scientists for their membrane protein research. The Cube Biotech team shares more than 40 years of experience on membrane protein expression, purification, and crystallization.

Purmeo

Seed Round in 2012
Purmeo GmbH retails customized vitamin packages online. The company was founded in 2011 and is based in Berlin, Germany.

Netbiscuits

Venture Round in 2012
Netbiscuits GmbH provides device detection tools that allow web developers to customize and optimize their website. The company offers Visitor ID, a visitor identification for cross-device marketing; Device Detection, an enterprise-grade solution for implementing an adaptive web strategy; Analytics that allows users to track data on their content marketing across tablet, smartphone, feature phone, PC, wearables, and more; and professional services. Netbiscuits GmbH was formerly known as Dynetic Solutions GmbH and changed its name in June 2008. The company was founded in 2000 and is headquartered in Kaiserslautern, Germany.

Hojoki

Series A in 2012
Hojoki is a team collaboration application that integrates various cloud services to streamline workflow and communication. It enables users to consolidate notifications from multiple platforms, allowing for real-time discussion and updates related to ongoing projects. The application supports a wide range of cloud tools, including Google Docs, Dropbox, Evernote, and GitHub, among others. By bringing together these disparate applications, Hojoki enhances productivity and facilitates seamless teamwork.

News Republic

Series A in 2012
News Republic, Inc. is a mobile media company headquartered in Bordeaux, France, with an additional presence in San Francisco. Founded in 2008, the company specializes in developing news applications that deliver a wide range of content, including articles, videos, and photos, sourced from numerous media partners worldwide. Its flagship apps, News Republic, AppyGeek, and AppyGamer, are available in six languages and cater to millions of users across various platforms, including iOS, Android, Windows 8, and Tizen. News Republic aims to enhance the news consumption experience through its proprietary semantic engine, which provides real-time contextual news tailored to individual preferences. The company has established strong partnerships with over 1,000 leading publishers and global media brands, as well as collaborations with hardware manufacturers and mobile network operators, further expanding its reach in the mobile news landscape.

Mobiles Republic

Series A in 2012
Mobiles Republic is a digital platform specializing in news applications for smartphones and tablets, based in Bordeaux Cedex, France. The company collaborates with over 800 prominent global and regional news sources, including Associated Press, The Huffington Post, and The Guardian. Its suite of mobile applications includes News Republic®, Appy Geek™, Appy Gamer™, Sports Republic™, and GlamLife™, catering to diverse interests. Mobiles Republic's innovative technology, particularly its proprietary TagNav® system, allows for personalized news delivery based on user preferences across more than one million topics. The platform generates over 10 million page views daily by providing licensed and trusted content, and it also serves as a technology partner for mobile innovations like BlinkFeed™, enhancing user experience on devices such as the HTC One smartphones.

Insiteo

Venture Round in 2011
Insiteo SAS develops indoor location service platform for smartphones. It provides services to smart buildings, events, retail stores, exhibitions, restaurants, shopping centers, museums, airports, and transport stations. The company offers indoor positioning solutions. Insiteo SAS was founded in 2009 and is based in Colomiers, France with additional offices in Paris, France; Amsterdam, Netherlands; and London, United Kingdom.

cloudControl

Series A in 2011
The cloudControl platform features agile deployments, rock-solid autoscaling infrastructure and pay-as-you-go pricing out of Amazon's European datacenters. With the cloudControl Add-on market they bring developers all the third party Cloud services they need easily integratable into their own apps and let them take projects from idea to product faster than ever before.

Sividon Diagnostics

Private Equity Round in 2011
Sividon Diagnostics GmbH develops a portfolio of treatment-related diagnostic tests. The company specializes in molecular tumor diagnostics. Its portfolio includes ImmunoPredict biomarker test. The company was founded in 2011 and is based in Cologne, Germany. Sividon Diagnostics GmbH operates as a subsidiary of Myriad Services GmbH.

Zadego

Venture Round in 2011
Easybooking for the tourism industry by Zadego

Shopgate

Series A in 2011
Shopgate GmbH specializes in mobile shopping solutions, providing a mobile-commerce-as-a-service platform that enhances mobile sales for online retailers. Founded in 2009 and headquartered in Butzbach, Germany, with additional offices in Frankfurt, Magdeburg, and Austin, Texas, Shopgate enables over 12,000 merchants to create, maintain, and optimize native apps and mobile websites for various devices, including iPhone, iPad, and Android smartphones and tablets. The company offers a user-friendly software-as-a-service (SaaS) that integrates with more than 60 popular shopping carts and collaborates with leading mobile payment providers, ensuring a seamless shopping experience for millions of customers daily. With a dedicated team of 141 individuals, Shopgate emphasizes innovation and customer satisfaction in the rapidly evolving mobile commerce market.

Cevec

Venture Round in 2011
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.

SIRION BIOTECH

Venture Round in 2011
Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery of new drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing. The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector. The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.

stylefruits

Series C in 2011
stylefruits GmbH operates a style advice platform for fashion and home design. Its platform allows users to create individual outfits by combining a selection of fashionable clothing and accessories in the categories of women's fashion, men's fashion, and interior design from a range of online partner shops; recommend, rate, and discuss styles with other users online; and share them on the social media sites. The company’s solution is available as online platform, and as an application for smartphones and tablets. It serves customers in Germany, the Netherlands, France, and the United Kingdom. The company was founded in 2008 and is based in Munich, Germany. As per the transaction announced on April 22, 2016, stylefruits GmbH operates as a subsidiary of Ströer SE & Co. KGaA.

Netbiscuits

Series B in 2011
Netbiscuits GmbH provides device detection tools that allow web developers to customize and optimize their website. The company offers Visitor ID, a visitor identification for cross-device marketing; Device Detection, an enterprise-grade solution for implementing an adaptive web strategy; Analytics that allows users to track data on their content marketing across tablet, smartphone, feature phone, PC, wearables, and more; and professional services. Netbiscuits GmbH was formerly known as Dynetic Solutions GmbH and changed its name in June 2008. The company was founded in 2000 and is headquartered in Kaiserslautern, Germany.

Tellja

Series B in 2011
Tellja provides digital recommendation marketing services. It began operation in 2009 as Pelvit, with its headquarters in Frankfurt in Germany.

Zimory

Venture Round in 2010
Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloud environments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.

Phenex (Biotechnology)

Series C in 2010
Phenex Pharmaceuticals AG is a drug discovery and development company founded in 2002, based in Ludwigshafen, Germany, with additional laboratories and offices in Heidelberg. The company specializes in small-molecule drug discovery, particularly focusing on nuclear receptors, and targets various disease areas, including liver diseases, gastrointestinal disorders, and cancer. Phenex is engaged in developing innovative therapeutics, such as RORγt inverse agonists for autoimmune diseases and FXR agonists for non-alcoholic steatohepatitis. The company aims not only to create new treatments for established targets but also to explore novel molecular mechanisms, which can lead to the development of proprietary small molecules with transformative potential. Through its research, Phenex seeks to translate scientific findings into effective therapies that improve current treatment regimens for liver and cancer patients.

JOIZ

Series A in 2010
joiz Group, founded in 2009 and based in Zurich, Switzerland, specializes in producing interactive cross-media entertainment programs aimed at audiences aged 15 to 29. The company focuses on engaging younger viewers through innovative content broadcasting, utilizing various platforms to enhance audience interaction and participation. With a commitment to delivering relevant and entertaining media experiences, joiz Group has established itself as a notable player in the entertainment industry, catering specifically to the preferences and interests of its target demographic.

Caprotec Bioanalytics

Series B in 2010
caprotec bioanalytics has developed a ground-breaking, proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner. caprotec's Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecules (Capture Compoundsâ„¢) that are used to target, capture, and isolate proteins based on their functionality. For many applications, CCMS is clearly superior to shotgun approaches - thus addressing an unmet need in the proteomics community.

stylefruits

Series B in 2010
stylefruits GmbH operates a style advice platform for fashion and home design. Its platform allows users to create individual outfits by combining a selection of fashionable clothing and accessories in the categories of women's fashion, men's fashion, and interior design from a range of online partner shops; recommend, rate, and discuss styles with other users online; and share them on the social media sites. The company’s solution is available as online platform, and as an application for smartphones and tablets. It serves customers in Germany, the Netherlands, France, and the United Kingdom. The company was founded in 2008 and is based in Munich, Germany. As per the transaction announced on April 22, 2016, stylefruits GmbH operates as a subsidiary of Ströer SE & Co. KGaA.

Cevec

Series B in 2010
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.

Sofialys

Venture Round in 2010
SOFIALYS is the leading mobile advertising and marketing service provider for operators, ad networks, advertisers (interactive agencies and brands), publishers and application developers. Since its inception in 2002, the company's unique goal has been to work with those actors of the value chain in order to facilitate the creation of a new ecosystem where the Mobile Phone would become a mass market media. Headquarters in France, SOFIALYS has developed a mobile advertising ad server, the Mobile Adbox, that allows the monetization of any types of mobile inventory including applications, mobile internet, SMS and Video. The Sofialys ad-server currently serves over 150 million impressions and 200 campaigns a month across Europe, Asia, Middle East, LATAM and the US. Sofialys also supports communication agencies and leading FMCG brands in the development and execution of their mobile strategy.

Cevec

Series A in 2009
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.

aka-aki

Venture Round in 2009
The berlin-based aka-aki team builds apps to discover the people nearby. with a little help from aki, a very well connected moose thanks to his antenna antlers

Tellja

Series A in 2009
Tellja provides digital recommendation marketing services. It began operation in 2009 as Pelvit, with its headquarters in Frankfurt in Germany.

News Republic

Seed Round in 2009
News Republic, Inc. is a mobile media company headquartered in Bordeaux, France, with an additional presence in San Francisco. Founded in 2008, the company specializes in developing news applications that deliver a wide range of content, including articles, videos, and photos, sourced from numerous media partners worldwide. Its flagship apps, News Republic, AppyGeek, and AppyGamer, are available in six languages and cater to millions of users across various platforms, including iOS, Android, Windows 8, and Tizen. News Republic aims to enhance the news consumption experience through its proprietary semantic engine, which provides real-time contextual news tailored to individual preferences. The company has established strong partnerships with over 1,000 leading publishers and global media brands, as well as collaborations with hardware manufacturers and mobile network operators, further expanding its reach in the mobile news landscape.

stylefruits

Series A in 2008
stylefruits GmbH operates a style advice platform for fashion and home design. Its platform allows users to create individual outfits by combining a selection of fashionable clothing and accessories in the categories of women's fashion, men's fashion, and interior design from a range of online partner shops; recommend, rate, and discuss styles with other users online; and share them on the social media sites. The company’s solution is available as online platform, and as an application for smartphones and tablets. It serves customers in Germany, the Netherlands, France, and the United Kingdom. The company was founded in 2008 and is based in Munich, Germany. As per the transaction announced on April 22, 2016, stylefruits GmbH operates as a subsidiary of Ströer SE & Co. KGaA.

Phenex (Biotechnology)

Series B in 2008
Phenex Pharmaceuticals AG is a drug discovery and development company founded in 2002, based in Ludwigshafen, Germany, with additional laboratories and offices in Heidelberg. The company specializes in small-molecule drug discovery, particularly focusing on nuclear receptors, and targets various disease areas, including liver diseases, gastrointestinal disorders, and cancer. Phenex is engaged in developing innovative therapeutics, such as RORγt inverse agonists for autoimmune diseases and FXR agonists for non-alcoholic steatohepatitis. The company aims not only to create new treatments for established targets but also to explore novel molecular mechanisms, which can lead to the development of proprietary small molecules with transformative potential. Through its research, Phenex seeks to translate scientific findings into effective therapies that improve current treatment regimens for liver and cancer patients.

video intelligence

Series A in 2008
vi is a contextual video platform. We connect publishers, content creators and brands with video storytelling. Our contextual matching engine finds the perfect videos to complement page text. So publishers increase engagement, content creators find new distribution outlets and advertisers reach attentive audiences. The result is users that spend longer on sites. Using machine learning, we help over 1,000 web publishers and 200 video creators to deliver millions of contextual video stories every day.

First1 Networks

Venture Round in 2008
First1 Networks GmbH provides interactive live game shows on the Internet. The company is based in Berlin, Germany.

Caprotec Bioanalytics

Series B in 2008
caprotec bioanalytics has developed a ground-breaking, proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner. caprotec's Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecules (Capture Compoundsâ„¢) that are used to target, capture, and isolate proteins based on their functionality. For many applications, CCMS is clearly superior to shotgun approaches - thus addressing an unmet need in the proteomics community.

Doodle

Series A in 2008
Doodle is an online scheduling service that simplifies the process of arranging events, including meetings, social gatherings, and appointments. By offering tools for both group scheduling and individual appointments, Doodle saves time for users by eliminating the hassle of finding a mutually convenient date and time. The platform is accessible without the need for registration for either the meeting organizer or participants, making it user-friendly. Doodle aims to facilitate connections among individuals by streamlining the scheduling process, thus enhancing collaboration and communication in both personal and professional contexts.

Netbiscuits

Series A in 2007
Netbiscuits GmbH provides device detection tools that allow web developers to customize and optimize their website. The company offers Visitor ID, a visitor identification for cross-device marketing; Device Detection, an enterprise-grade solution for implementing an adaptive web strategy; Analytics that allows users to track data on their content marketing across tablet, smartphone, feature phone, PC, wearables, and more; and professional services. Netbiscuits GmbH was formerly known as Dynetic Solutions GmbH and changed its name in June 2008. The company was founded in 2000 and is headquartered in Kaiserslautern, Germany.

WiredMinds

Venture Round in 2006
WiredMinds’ core product “lead lab sales” generates new b2b sales leads via corporate websites. The company’s core product identifies a website’s enterprise-visitors and automatically retrieves company and contact information of the visitor. The system checks whether the visitor is a potential customer and inherent interfaces allow an easy transfer of the new lead into existing CRM systems. Further actions are triggered automatically, i.e., sales people are informed about the new lead or the lead will be subscribed to a newsletter. The company was founded in 2002 and is the market leader in automatic lead generation for enterprise customers. Strategic position: Enterprise webpages usually purely act as a source of information rather than a means to acquire new customers. More and more businesses discover the possibility to identify new business leads through their website. WiredMinds offers a unique and highly scalable Sales Automation solution, unleashing the full potential of a corporate website. Over the last years the company has won a number of attractive enterprise customers and publishers such as Heise Zeitschriften Verlag, Motorpresse, Osram and Porsche.

Alrise Biosystems

Venture Round in 2005
Alrise Biosystems GmbH is a drug-delivery company based in Berlin, Germany, specializing in advanced nano and micro-encapsulation technologies for drug development. Founded in 2004, the company focuses on creating controlled-release formulations targeted at the gastrointestinal tract, utilizing its patented ImSus technology. This innovative platform allows for the encapsulation of both hydrophilic and hydrophobic drugs, accommodating a wide range of molecule sizes from small molecules to peptides and proteins. Alrise develops depot formulations for injectable drugs, particularly designed for long-acting applications that provide patient protection while minimizing risk. By offering unique drug delivery solutions, Alrise aims to meet the growing demands of pharmaceutical, biotech, and generics companies, ultimately benefiting patients worldwide.

Jaron Direct

Series A in 2004
Jaron Direct is an online marketing agency.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.